Pharmaceutical formulations
US10966922B2 · kind B2 · utility
0Cited by
19References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2019 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Jul 12, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.